Tyrosine Kinase Inhibitors for the Elderly

Until few years ago non-specific cytotoxic agents were considered the tip of the arrow as first line treatment for lung cancer. However; age > 75 was considered a major drawback for this kind of therapy. Few exceptions were made by doctors based on the performance status of the patient. The side...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul, Steinheimer, Michael, Benhassen, Naim, Tsiouda, Theodora, Baka, Sofia, Yarmus, Lonny, Stratakos, Grigoris, Organtzis, John, Pataka, Athanasia, Tsakiridis, Kosmas, Karapantzos, Ilias, Karapantzou, Chrysanthi, Darwiche, Kaid, Zissimopoulos, Athanasios, Pitsiou, Georgia, Zarogoulidis, Konstantinos, Man, Yan-Gao, Rittger, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829555/
https://www.ncbi.nlm.nih.gov/pubmed/27076850
http://dx.doi.org/10.7150/jca.14819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829555/
https://www.ncbi.nlm.nih.gov/pubmed/27076850
http://dx.doi.org/10.7150/jca.14819

Ejemplares similares